Recursion Pharmaceuticals, Inc.
RXRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001601830
In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Recursion Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +42 vs. Q3 2021
- Shares held
- 94.3M
- +39.4M (+71.8%) vs. Q3 2021
- Total value
- $1.62B
- +$353.2M (+28.0%) vs. Q3 2021
- New holders
- 53
- 52 more added
- Sold out
- 11
- 10 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 344 | $1.33B |
| Q1 2026 | 335 | $1.03B |
| Q4 2025 | 335 | $1.33B |
| Q3 2025 | 322 | $1.58B |
| Q2 2025 | 333 | $1.57B |
| Q1 2025 | 337 | $1.63B |
| Q4 2024 | 316 | $2.06B |
| Q3 2024 | 268 | $1.74B |
| Q2 2024 | 270 | $1.89B |
| Q1 2024 | 248 | $2.12B |
| Q4 2023 | 199 | $2.04B |
| Q3 2023 | 192 | $1.16B |
| Q2 2023 | 158 | $952.8M |
| Q1 2023 | 159 | $841.4M |
| Q4 2022 | 144 | $954.0M |
| Q3 2022 | 146 | $1.21B |
| Q2 2022 | 133 | $861.1M |
| Q1 2022 | 128 | $680.3M |
| Q4 2021 | 126 | $1.62B |
| Q3 2021 | 84 | $1.26B |
| Q2 2021 | 75 | $1.71B |
| Q1 2021 | 1 | $1.00K |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Recursion Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 539,236 | $9.24M | 1.84% | −213,703−28.4% | Reduced |
| Casdin Capital, LLC | 548,156 | $9.39M | 0.26% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 857,573 | $14.7M | 0.00% | +276,903+47.7% | Added |
| Northern Trust Corp | 885,961 | $15.2M | 0.00% | +635,290+253.4% | Added |
| Comprehensive Financial Management LLC | 1,109,395 | $19.0M | 0.24% | 00.0% | Unchanged |
| Botty Investors LLC | 1,255,430 | $21.5M | 6.38% | +1,255,430 | New |
| Geode Capital Management, LLC | 1,294,957 | $22.2M | 0.00% | +732,626+130.3% | Added |
| Massachusetts Financial Services Co | 1,300,041 | $22.3M | 0.01% | +404,181+45.1% | Added |
| MIC Capital Management UK LLP | 1,388,889 | $23.8M | 4.62% | +1,388,889 | New |
| Norges Bank | 1,397,274 | $23.9M | 0.00% | +897,274+179.5% | Added |
| Platinum Investment Management Ltd | 1,443,863 | $24.7M | 0.69% | +782,160+118.2% | Added |
| Harvard Management Co Inc | 1,509,254 | $25.9M | 2.43% | 00.0% | Unchanged |
| FMR LLC | 1,530,226 | $26.2M | 0.00% | −429,737−21.9% | Reduced |
| Credit Suisse AG | 1,559,618 | $26.7M | 0.02% | +109,022+7.5% | Added |
| Two Sigma Ventures, LP | 1,806,800 | $30.9M | 61.39% | +1,806,800 | New |
| MV Management XI, L.L.C. | 1,971,908 | $33.8M | 14.59% | +1,971,908 | New |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,232,013 | $38.2M | 0.12% | −361,823−13.9% | Reduced |
| Alliancebernstein L.P. | 2,875,819 | $49.3M | 0.02% | +1,236,478+75.4% | Added |
| Laurion Capital Management LP | 3,923,713 | $67.2M | 1.16% | 00.0% | Unchanged |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $67.7M | 33.92% | +3,951,141 | New |
| State Street Corp | 4,656,727 | $79.8M | 0.00% | +3,012,233+183.2% | Added |
| Data Collective IV GP, LLC | 5,941,120 | $101.8M | 13.74% | +5,941,120 | New |
| Obvious Management Services, L.L.C. | 5,977,631 | $102.4M | 87.10% | +5,977,631 | New |
| Vanguard Group Inc | 6,113,873 | $104.7M | 0.00% | +3,401,893+125.4% | Added |
| BlackRock Inc. | 6,762,684 | $115.8M | 0.00% | +4,995,020+282.6% | Added |
| Baillie Gifford & Co | 22,123,155 | $379.0M | 0.21% | +61,781+0.3% | Added |
| Mic Capital Partners (Public) (US) Im, LLC | 0 | $0 | 0.00% | −1,388,889−100.0% | Sold out |
| CRV, LLC | 0 | $0 | 0.00% | −733,986−100.0% | Sold out |
| Alkeon Capital Management LLC | 0 | $0 | 0.00% | −548,455−100.0% | Sold out |
| Yong Rong (HK) Asset Management Ltd | 0 | $0 | 0.00% | −377,000−100.0% | Sold out |
| HBK Investments L P | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Ratan Capital Management LP | 0 | $0 | 0.00% | −35,069−100.0% | Sold out |
| Samson Rock Capital LLP | 0 | $0 | 0.00% | −10,278−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −2,987−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −2,777−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −1,340−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −208−100.0% | Sold out |